The Patient Activation Measure® (PAM®) suite of tools from Insignia Health is proven to:
- Strengthen risk-identification and improve predictive modeling
- Reduce avoidable hospital and emergency department utilization
- Personalize support to improve patient self-management behaviors
- Improve patient outcomes and elevate patient satisfaction
Selected by CMS as a MACRA performance improvement measure for beneficiary engagement.
Adopted by NHS England for system-wide use within clinics, hospitals and social services.
PAM, CFA and Flourish are licensed exclusively by Insignia Health. Let us show you how these PAM-based solutions can work for your organization.
Drive success in value-based care by improving care transitions and reducing preventable admissions.
Better identify risk, allocate resources more effectively and strengthen cost control programs.
Understand patient self-management capabilities to better tailor coaching support for each individual.
Understand how patient activation directly affects medication and treatment adherence to improve patient outcomes.
Assessing patient activation may help customize IBD interventions
Patients with inflammatory bowel disease who showed high levels of “patient activation” were less likely to experience disease flare during follow-up, according to new research presented at the Crohn’s & Colitis Congress by Edward Barnes, MD, MPH assistant professor of medicine in the division of gastroenterology and hepatology at University of North Carolina, Chapel Hill.Read More
PharmOutcomes Integrates the Patient Activation Measure® survey to improve continuity of care for community pharmacies
Community pharmacies and healthcare providers across England can assess patient activation using PharmOutcomes® and tailor patient support to achieve better outcomes. Insignia Health’s Patient Activation Measure® (PAM®) is now available to community pharmacies and other commissioning organisations across England through PharmOutcomes.Read More